Atlas Trials

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Clinical trial NCT02811783 · TERMINATED

Trial details

NCT number
NCT02811783
Sponsor
Elorac, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Mycosis FungoidesLymphoma, T-Cell, CutaneousSézary Syndrome
Start date
2017-01-01
Primary completion
2022-09-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.